SMYD2-mediated EZH2 di-methylation at lysine 307 (K307) activates and elevates its stability, which can be demethylated by the histone H3K4 lysine-specific demethylase 1 (LSD1) in BC [11,12,13]. Here, EZH2 is linked to breast cancer.